German American names Mary Moorhouse Chief Risk Officer
JASPER, Ind., March 28, 2024 (GLOBE NEWSWIRE) — German American Bancorp, Inc. (Nasdaq: GABC) announced today that Mary Moorhouse has […]
Highest Performances Announces Acquisition of an AI Humanoid Robot Hardware Manufacturer
GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) — Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), a leading […]
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical […]
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) — FibroBiologics (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and […]
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of […]
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
Advanced OTX-2002 in MYCHELANGELO™ I trial; initial cohorts demonstrated encouraging disease control rate in late-stage HCC patients Established a research […]
PubMatic Reinvests 2023 Profits in Team Expansion to Accelerate Revenue Growth
NO-HEADQUARTERS/REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) — PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply […]
BayFirst Financial Corp. Announces First Quarter 2024 Conference Call and Webcast
ST. PETERSBURG, Fla., March 28, 2024 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or the “Company”), parent company […]
Progress Releases Corporate Social Responsibility Report for 2023
Fifth annual report underscores company’s unwavering commitment to inclusion and diversity, charitable giving and sustainability BURLINGTON, Mass., March 28, 2024 […]
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing […]
